skip to Main Content

Validation requirements for pharmaceutical

Validation is a meticulous and meticulous process that must be adjusted on a case-by-case basis. In this document, we deal with the most important principles. If you would like more details, you will find some links to resources provided by the FDA, WHO and ISPE (International Society of Pharmaceutical Engineers) at the end of this document. As this is a dynamic field that is not suitable for one-size-fits-all solutions, it can be useful to hire an external consultant for complex validation projects. In terms of regulatory compliance, if the FDA identifies issues with your validation process, it can issue a public warning letter or Form 483 (“Inspection Observations”). The problems can then be corrected by corrective actions. Ongoing and unresolved issues can result in recalls, product seizures, or even civil penalties. Since process validation covers the entire life cycle of a pharmaceutical product, the FDA defines three principles as guidelines for manufacturers. Learn how Tulip can help you make data collection and validation a seamless and seamless part of your production process. Next, let`s review the three steps for performing validation as defined by the FDA. The team responsible for planning and executing the validation should be composed of all relevant departments (operations, purchasing, testing, and others), as well as a variety of technical experts. User Requirements Specification (URS): It contains the list of customer requirements/expectations for the equipment. The general requirements of the client are as follows: The validation process is the documented evidence that provides a high degree of certainty for a desired result with prederminated compliance.

The term validation is widely used in the pharmaceutical industry. This term comes from the word “valid or valid,” which means “legally defined.” The concept of validation was first proposed by the Food and Drug Administration (FAD) in the mid-1970s to improve the quality of pharmaceuticals. Like a variety of procedures, methods or activations are validated to verify and improve their quality. [1-3] The validation or subsequent verification of computer systems is limited to the “GxP-critical” requirements of computer systems. Evidence (e.g., screen prints) is collected to document validation. This ensures that systems are thoroughly tested and that validation and documentation of “critical GxP” aspects are risk-based, optimizing effort and ensuring that the ease of use of the IT system is demonstrated. Cleaning validation: Cleaning validation provides a documented facility with a high level of assurance that a particular system, piece of equipment or equipment will be cleaned consistently at predetermined quality and acceptable limits. Pharmaceuticals are contaminated with a variety of substances such as lubricants, airborne solids, prepared product residues and microbes. Therefore, proper cleaning procedures play an important role in avoiding contamination and cross-contamination. [1,5] Some organizations, such as small businesses or companies that do not regularly perform validation activities, may not have the expertise or in-house resources to perform validation effectively. Many of the world`s leading pharmaceutical and medical device manufacturers use our qualified GXP platform to manage operators` activities and business processes while automating data collection and providing a detailed record of all actions throughout the product lifecycle.

Together, these procedures ensure that manufacturers` products meet the requirements and specifications necessary to achieve their intended purpose. As mentioned earlier, validation in the pharmaceutical industry is about ensuring that the relevant production processes comply with established guidelines, resulting in a consistent, high-quality and safe product that meets consumer requirements. Essentially, validation is an accepted method when key quality measures cannot be measured, tested and verified. The purpose of validation is to integrate the quality, safety and efficacy of the finished drug and not to rely on post-production batch testing. To achieve this, you need to ensure that every step of the process works as expected, based on quality design, with the ultimate goal being consistent reproducibility. This validation process is continuous and takes place throughout the product lifecycle, from development to commercial production. The validation process of pharmaceutical devices in the pharmaceutical industry is quite simple to carry out. The various steps of the process are thoroughly reviewed and documented in accordance with the approval of the pharmaceutical industry/pharmaceutical company. The procurement process typically begins with the creation of the required documentation and User Requirements Specification (URS). In order to carry out a project/validation plan (VP), some form of change request (CR) must be taken from existing facilities. The management having previously agreed to move forward, the request to carry out a validation project (VP) is granted.

Then, with an approved VP, the required validation protocol to verify that all requirements documented in the URS and all cGMP requirements are met. The plan should also identify triggering events for reviewing validation processes, such as major changes to regulations, production line, personnel, facilities, or organizational structure. Application of Device Validation: The following describes the importance of device validation in the pharmaceutical industry. [14] Revalidation: Revalidation is performed when equipment and system have been modified in any way for any reason. Equipment revalidation is very useful in maintaining the validation state of the equipment and the entire system functioning as a unit. The revalidation process is also used to periodically review the validation in accordance with government guidelines. [4,5,12] In recent years, a risk-based approach has been adopted in industry, where computer system testing (emphasis on problem finding) is thorough and documented, but not well documented (i.e., hundreds of screen prints are not collected during testing). Annex 11 states: “Risk management should be applied throughout the life cycle of the computerized system, taking into account patient safety, data integrity and product quality. As part of a risk management system, decisions on the scope of validation and data integrity checks should be based on a reasoned and documented risk assessment of the computerised system. » Device validation phases [Figure 3]: The device validation process is mainly divided into three phases:[6,7] 2. Installation Qualification (IQ) – Documented evidence that the equipment or systems, as installed or modified, conform to the approved design, manufacturer`s recommendations and/or user requirements. Probably the best-known industry guide is the GAMP Guide, now in its fifth edition and known as GAMP5 and published by ISPE (2008). [9] This guide provides practical advice on how to meet regulatory requirements.

The first pillar of process validation is the development of a commercial process that allows manufacturers to develop a particular drug or product. The design of this business process requires details and knowledge gained during the research and development phase. For complex products such as biopharmaceuticals, gene and cell therapies, it can be difficult to determine which attributes should be included in the CQs, even after commercial production has begun.

Back To Top